Boothbay Fund Management, LLC Eye Point Pharmaceuticals, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$19.93 - $29.71 $639,753 - $953,691	-32,100 Reduced 34.33%	61,400 $1.27 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $533,885 - $2.26 Million	93,500 New	93,500 $2.16 Million
Q3 2021 Nov 15, 2021	SELL	$7.51 - $11.72 $182,493 - $284,796	-24,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.69 - $11.08 $211,167 - $269,244	24,300 New	24,300 $218,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $312M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.